- Home
- LRMR vs NEWP Comparison
LRMR vs NEWP Comparison
Compare LRMR & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- NEWP
- Stock Information
- Founded
- LRMR N/A
- NEWP 1972
- Country
- LRMR United States
- NEWP Canada
- Employees
- LRMR N/A
- NEWP N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- NEWP
- Sector
- LRMR Health Care
- NEWP
- Exchange
- LRMR Nasdaq
- NEWP Nasdaq
- Market Cap
- LRMR 183.8M
- NEWP 199.1M
- IPO Year
- LRMR N/A
- NEWP N/A
- Fundamental
- Price
- LRMR $2.18
- NEWP $1.44
- Analyst Decision
- LRMR Strong Buy
- NEWP Strong Buy
- Analyst Count
- LRMR 8
- NEWP 1
- Target Price
- LRMR $19.63
- NEWP $5.00
- AVG Volume (30 Days)
- LRMR 1.3M
- NEWP 262.4K
- Earning Date
- LRMR 04-30-2025
- NEWP 05-07-2025
- Dividend Yield
- LRMR N/A
- NEWP N/A
- EPS Growth
- LRMR N/A
- NEWP N/A
- EPS
- LRMR N/A
- NEWP N/A
- Revenue
- LRMR N/A
- NEWP N/A
- Revenue This Year
- LRMR N/A
- NEWP N/A
- Revenue Next Year
- LRMR N/A
- NEWP N/A
- P/E Ratio
- LRMR N/A
- NEWP N/A
- Revenue Growth
- LRMR N/A
- NEWP N/A
- 52 Week Low
- LRMR $1.61
- NEWP $0.93
- 52 Week High
- LRMR $11.20
- NEWP $2.11
- Technical
- Relative Strength Index (RSI)
- LRMR 54.85
- NEWP 66.49
- Support Level
- LRMR $1.80
- NEWP $1.35
- Resistance Level
- LRMR $2.33
- NEWP $1.46
- Average True Range (ATR)
- LRMR 0.18
- NEWP 0.08
- MACD
- LRMR 0.04
- NEWP 0.02
- Stochastic Oscillator
- LRMR 90.00
- NEWP 96.23
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.